Top 10 FDA Recalls Physicians Should Know
-
By
-
mdspire news news staff
-
June 18, 2026
-
5 min
By
mdspire news news staff
June 18, 2026
Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.
July 16, 2026
by Charat Thongprayoon, Francesco Pesce, Wisit Cheungpasitporn
July 10, 2026
The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.
July 8, 2026